EP Patent

EP1944032A3 — Biodegradable intraocular implants containing prostamides

Assigned to Allergan Inc · Expires 2010-10-06 · 16y expired

What this patent protects

The present invention relates to microspheres comprising: a prostamide component and a biodegradable polymer matrix. The invention also relates to biodegradable intraocular implants.

USPTO Abstract

The present invention relates to microspheres comprising: a prostamide component and a biodegradable polymer matrix. The invention also relates to biodegradable intraocular implants.

Drugs covered by this patent

Lumigan (BIMATOPROST)

Patent Metadata

Patent number: EP1944032A3
Jurisdiction: EP
Classification: —
Expires: 2010-10-06
Drug substance claim: No
Drug product claim: No
Assignee: Allergan Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.